Growth Metrics

Northwest Biotherapeutics (NWBO) Amortizatization of Intangibles (2016 - 2025)

Northwest Biotherapeutics' Amortizatization of Intangibles history spans 15 years, with the latest figure at $73000.0 for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $73000.0 for Q4 2025, up 14.06% from a year ago — trailing twelve months through Dec 2025 was $273000.0 (down 9.0% YoY), and the annual figure for FY2025 was $273000.0, down 9.0%.
  • Amortizatization of Intangibles for Q4 2025 was $73000.0 at Northwest Biotherapeutics, up from $70000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $93000.0 in Q1 2021 to a low of $56000.0 in Q2 2021.
  • The 5-year median for Amortizatization of Intangibles is $70000.0 (2025), against an average of $70200.0.
  • Peak annual rise in Amortizatization of Intangibles hit 16.25% in 2021, while the deepest fall reached 33.72% in 2021.
  • Year by year, Amortizatization of Intangibles stood at $57000.0 in 2021, then rose by 10.53% to $63000.0 in 2022, then rose by 15.87% to $73000.0 in 2023, then dropped by 12.33% to $64000.0 in 2024, then increased by 14.06% to $73000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $73000.0, $70000.0, and $66000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.